What's this about?
Three Anthropic announcements landed this week: Claude for Teachers, a version of Claude tailored to K-12 educators (Jul 14); a $10 million commitment to Canadian AI research (Jul 14); and open applications for AI-for-Science grants specifically targeting rare disease research (Jul 20).
What exactly is "AI for Science"?
It's Anthropic's grant and product initiative aimed at accelerating scientific research with Claude — funding researchers' compute/API access and, separately, building science-specific tools like Claude Science (a research workbench announced earlier this summer). Rare diseases are a natural target: they're individually under-resourced for pharma R&D (too few patients per disease to be commercially attractive) but collectively affect hundreds of millions of people, making them a good fit for AI-accelerated research that doesn't need a blockbuster-drug business case.
Why does it matter?
No discussion signal on any of these (routine announcements, not deep technical content) — they're a snapshot of Anthropic's non-frontier-model business this week: education, philanthropy-adjacent research funding, and public-sector-flavored science grants, running in parallel with the frontier-model and safety work covered elsewhere in this digest.